Drugs / Angong Niuhuang Pill (ANP)
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06723366 | Jan → Dec 2025 overdue | brain injury, cerebrovascular disorder | Nanjing Medical University | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Angong Niuhuang Pill (ANP) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06723366 ↗ |
| Known as | ANP | “Angong Niuhuang Pill (ANP) (3 g/pill, 1 pill/day for 5 days)” NCT06723366 ↗ |